If your LDL is normal, your ApoB is too
Short answerNot the way you think
On this page
Not the way you think. For most people a normal LDL does come with a normal ApoB. But the two split most often in people with high triglycerides, diabetes, extra weight or a statin, and in a Copenhagen study, statin users with a high ApoB and a low LDL had about 1.5 times the heart attacks of people with both low.
What we’d do
If your triglycerides are 150 or more, you have diabetes or prediabetes, you carry extra weight around your middle, or you take a statin, don’t let a normal LDL end the conversation. Ask for ApoB. If it comes back over the goal for your risk, plan around it, and start with the changes that lower the particle count. If none of those apply and your LDL was worked out with a modern formula, your LDL is probably telling you most of the story.
If you remember three things
- They usually agree. In UK Biobank the two lined up at a correlation of 0.96.
- They split in the people at most risk. High triglycerides, diabetes, extra weight and statins.
- When they split, risk follows ApoB. The 2026 guideline says so in as many words.
Why people believe it
LDL is the number every doctor has looked at for decades, and it’s the one with goals on nearly every report. ApoB and LDL also move together most of the time. In UK Biobank, a study of 293,876 British adults, the correlation between them was 0.96. If your LDL is fine, it’s a fair bet your ApoB is too.
The problem is who loses that bet. The 2026 US guideline says the split “is most common in individuals with cardiometabolic disease, including ASCVD, CKM syndrome, diabetes, and/or TG ≥150 mg/dL”. That means heart disease, kidney and metabolic disease, diabetes, or triglycerides of 150 or more. They’re the people who most need an accurate number.
How a normal LDL hides a high count
LDL measures how much cholesterol sits inside your LDL particles. ApoB counts the particles. If each particle carries less cholesterol than usual, you need more of them to make the same LDL. The National Lipid Association’s 2024 consensus says high triglycerides, obesity and insulin resistance “can lead to smaller cholesterol-depleted LDL particles and result in lower LDL-C but still elevated apoB levels”.
Statins can do it too. They tend to clear the bigger, more cholesterol-rich particles first, so LDL falls further than the count.
Like a parking lot of motorcycles
Weigh every vehicle in a parking lot and you get one number. Count them and you get another. A lot full of motorcycles weighs less than a lot of pickup trucks, but it can hold far more vehicles. LDL is the weight and ApoB is the count, and the artery wall gets hit by vehicles, whatever they weigh.
That square places a 45 year old man with an LDL of 95 and an ApoB of 112. His LDL is under 100 and at about the 30th percentile of untreated American adults. His ApoB is at about the 79th. He’s in the corner called hidden count.
What happened to the people in that corner
On statins, in Copenhagen
13,015 statin users, followed about 8 years. Johannesen and colleagues, JACC, 2021
People with ApoB above the median and LDL below it had 1.49 times the heart attacks and 1.21 times the deaths of people with both below. High LDL with low ApoB wasn’t linked to more of either.
Everyone was on a statin, so it tells us most about treated people.
One LDL, a spread of counts
293,876 UK Biobank adults aged 40 to 73. Sniderman and colleagues, European Heart Journal, 2024
At an LDL of about 130, 95% of people had an ApoB between 86 and 109. Those at the high end had nearly twice the 10-year rate of new heart disease and strokes of those at the low end (7.3 against 4.0).
It shows who got sick, not what lowering ApoB did.
Young adults
2,794 Americans aged 18 to 30, followed 25 years. CARDIA, JACC, 2016
A high ApoB with a low LDL at the start came with 1.55 times the odds of calcium in the heart arteries by midlife.
Calcium is a sign of plaque, not a heart attack.
The best case for the myth
A skeptic would say most of the split comes from how LDL is worked out, and they’d be partly right. Many labs still calculate LDL with an old formula, Friedewald, which the guideline says gets less accurate as triglycerides rise and LDL falls. With the newer Martin/Hopkins method, the guideline says, only about 2% of people with an LDL under 70 and about 1% under 100 had an ApoB and non-HDL over their goals.
That’s a good reason to ask which formula your lab used. It doesn’t settle the matter, because you can’t tell whether you’re in that 2% without measuring, and the people most likely to be there are the ones at most risk. The guideline’s own words are that “ApoB predicts ASCVD risk more accurately than LDL-C in cases of disagreement”.
What to do
- Check whether you’re in a split-prone group. Triglycerides of 150 or more, diabetes or prediabetes, extra weight, or a statin.
- Ask for ApoB with your next panel. No fasting needed.
- Put both numbers in the corners. Do my ApoB and LDL agree? shows which corner you’re in and what it means.
6 sources
- Johannesen CDL and others, Apolipoprotein B and non-HDL cholesterol better reflect residual risk than LDL cholesterol in statin-treated patients, JACC, 2021pubmed.ncbi.nlm.nih.gov
- Sniderman AD and others, ApoB, non-HDL cholesterol and triglycerides in 293,876 UK Biobank adults, European Heart Journal, 2024pmc.ncbi.nlm.nih.gov
- Blumenthal RS, Morris PB, Gaudino M and others, 2026 ACC/AHA guideline on the management of dyslipidemia, JACC and Circulation, 13 March 2026doi.org
- The same guideline, full text, Circulation, 2026api.iscpcardio.org
- Soffer DE, Marston NA, Maki KC and others, Role of apolipoprotein B in the clinical management of cardiovascular risk in adults: an Expert Clinical Consensus from the National Lipid Association, Journal of Clinical Lipidology, 2024pmc.ncbi.nlm.nih.gov
- Wilkins JT and others, Discordance between apolipoprotein B and LDL-cholesterol in young adults predicts coronary artery calcification: the CARDIA study, JACC, 2016pmc.ncbi.nlm.nih.gov
